Elicio Therapeutics (ELTX) FCF Margin (2020 - 2022)
Elicio Therapeutics' (ELTX) quarterly FCF Margin came in at 849.77% in Q2 2022, up 279940.0% YoY from N/an in Q2 2021, and up 189.63% on a QoQ basis from 948.12% in Q1 2022.
Elicio Therapeutics (ELTX) FCF Margin (2020 - 2022) Analysis & Trends
Elicio Therapeutics (ELTX) has 3 years of FCF Margin data on file, last reported at 849.77% in Q2 2022.
- Quarterly FCF Margin rose 279940.0% year-over-year to 849.77% in Q2 2022, while the trailing twelve-month figure through Mar 2023 was 2235.22% (down 204704.0% YoY) and the FY2022 annual result came in at 958.93%, down 77298.0% from the prior year.
- FCF Margin improved to 849.77% in Q2 2022, from 948.12% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 4485.19% in Q4 2020 to a low of 3394.07% in Q1 2021.
- A 3-year average of 717.74% and a median of 1040.68% in 2021 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2021 — FCF Margin sank 454044 bps — and 2022, when it jumped 279940 bps.
- Tracing ELTX's FCF Margin over 3 years: stood at 4485.19% in 2020, then plunged by 101 bps to 55.25% in 2021, then jumped by 1638 bps to 849.77% in 2022.
- The last three FCF Margin figures came in at 849.77% (Q2 2022), 948.12% (Q1 2022), and 55.25% (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Elicio Therapeutics | 59.08 Mn | 35.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 849.77% |
| Mar 31, 2022 | -948.12% |
| Dec 31, 2021 | -55.25% |
| Sep 30, 2021 | -1,040.68% |
| Jun 30, 2021 | -1,949.63% |
| Mar 31, 2021 | -3,394.07% |
| Dec 31, 2020 | 4,485.19% |
| Sep 30, 2020 | -2,653.20% |
| Jun 30, 2020 | -1,753.64% |